Salarius Pharmaceuticals Inc (SLRX) earnings · $4.9M cap
These earnings events as JSON? API free 100/daySalarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
This SLRX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported SLRX revenue for 2026-06-30 was $227.6K. Net income was -$2.4M. SLRX currently screens at market cap $4.9M.
When the next SLRX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for SLRX. We will not invent a beat or miss.
Not investment advice. Full SLRX research stays on the stock page; the tape stays on the quote page.
SLRX earnings FAQ
What are SLRX's latest revenue and net income?
Latest cached Salarius Pharmaceuticals Inc (SLRX) revenue for Jun 30, 2026 was $227.6K. Net income was -$2.4M. Statements: https://lician.com/financials/slrx
What is SLRX's latest diluted EPS?
Latest cached Salarius Pharmaceuticals Inc (SLRX) diluted EPS for Jun 30, 2026 was -$4.46.
What period does the latest SLRX earnings print cover?
The latest cached Salarius Pharmaceuticals Inc (SLRX) earnings print covers Jun 30, 2026. The prior cached period on this page is Jun 30, 2025.
Where are SLRX earnings listed?
Cached earnings facts for Salarius Pharmaceuticals Inc (SLRX) are listed at https://lician.com/earnings/slrx. Statements: https://lician.com/financials/slrx
Not investment advice.